This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Scientiam Pharma, Women & Infants Hospital of Rhode Island. Active years: 2026.
Company Filing History:
1 out of 8,807 
1 out of 1 
1 out of 15 Years Active: 2026
Title: Clémence Disdier: Innovator in Neonatal Treatment
Introduction
Clémence Disdier is an inventor based in Gif sur Yvette, France. He has made significant contributions to the field of medicine, particularly in the treatment of neonatal conditions. Although he currently holds no granted patents, his work is noteworthy for its potential impact on healthcare.
Latest Patent Applications
Clémence Disdier's latest patent application is titled "Purine Derivatives as Drugs for the Treatment of Neonatal Hypoxia-Ischemia Brain Injury and Related Diseases." This application describes a compound of formula (I) for use in the treatment of non-traumatic acquired brain injury. The focus of this research is to address critical health issues affecting newborns.
Conclusion
Clémence Disdier's innovative work in neonatal treatment highlights the importance of research in improving health outcomes for vulnerable populations. His contributions, although not yet reflected in granted patents, pave the way for future advancements in medical science.